TABLE 4

Positivity rate of each test in patients with CPA caused by non-fumigatus Aspergillus spp.

TestaNo. of patients positive/no. tested (%)
Serum AspLFD6/9 (66.7)
BAL fluid AspLFD5/8 (62.5)
Serum GM (COI, 1.54)2/9 (22.2)
BAL fluid GM (COI, 0.6)3/9 (33.3)
Serum BDG (cutoff, 19.3 pg/ml)6/9 (66.7)
Aspergillus precipitating antibody2/9 (22.2)
  • a AspLFD, Aspergillus-specific lateral-flow device test; BAL, bronchoalveolar lavage; GM, galactomannan; BDG, β-d-glucan.